Marek Malecki

Summary

Publications

  1. pmc Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B
    Marek Malecki
    Phoenix Biomolecular Engineering Foundation, San Francisco, CA, USA
    Clin Transl Med 5:32. 2016
  2. pmc Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
    Marek Malecki
    Phoenix Biomolecular Engineering Foundation, San Francisco, CA, USA
    Clin Transl Med 5:44. 2016
  3. doi request reprint Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and sequencing
    Marek Malecki
    University of Wisconsin, Madison, WI 53706, USA
    Gene 493:132-9. 2012

Detail Information

Publications4

  1. pmc Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis B
    Marek Malecki
    Phoenix Biomolecular Engineering Foundation, San Francisco, CA, USA
    Clin Transl Med 5:32. 2016
    ..However, no prophylactic vaccine is available against HER-2(+) breast cancers. Although, prophylactic vaccine for human hepatitis B virus (HBV) is very effective...
  2. pmc Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
    Marek Malecki
    Phoenix Biomolecular Engineering Foundation, San Francisco, CA, USA
    Clin Transl Med 5:44. 2016
    ..Passive immunotherapy of ovarian cancers offers only low efficacy. Prophylactic and therapeutic vaccines for ovarian cancers are not available. Interestingly, prophylactic vaccines for Hepatitis B Viruses (HBV) are very effective...
  3. doi request reprint Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and sequencing
    Marek Malecki
    University of Wisconsin, Madison, WI 53706, USA
    Gene 493:132-9. 2012
    ....